Stock Notes

Alkem Laboratories

Every Finvezto stock note on Alkem Laboratories, dated and newest first. Coverage spans pharma.

1 note and counting
03 Jun 2026
Alkem Laboratories launched a single-shot semaglutide pre-filled syringe at ₹350, the first such format commercially available in India.
Over 50 generic semaglutide brands entered the market after Novo Nordisk's Indian patent expired on March 21, 2026.

Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630. Stock notes are market commentary for general information and education. They are not investment advice, not a recommendation to buy or sell, and do not account for any individual's financial situation. Investment in securities is subject to market risks. Please read all related documents carefully before investing. Past performance is not a guarantee of future results.